The rising complexity of heart disease requires new ways of treatment, which is less about choosing between open surgery vs. catheter-based procedures and more about blending all options into an entirely customizable treatment plan for each individual.
More than 21 percent of deaths are attributed to heart disease, yet gender and racial disparities in care are vast. To change the tide we need dedicated care focused on improving these outcomes.
Heart disease and stroke are the leading causes of death in the United States, and the U.S. Preventative Services Task Force just updated the guidelines for aspirin use in heart disease. Here's what you need to know.
Dr. Craig Smith breaks with the conventional wisdom on tying surgical knots. Here, Dr. Smith takes us through the anatomy of a knot to show us a better, more effective way to tie them—like a heart surgeon.
Part three of three explores the ways the medical and surgical sides of treatment now work together. An interview with Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation.
Part two of three on the latest in LVAD [left ventricular assist device] and heart transplantation. An interview with Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation.
The impact of the results from low-risk TAVR trials will be felt for many years. It will be felt by a wide group - surgeons, cardiologists, hospital systems, insurance companies, and most importantly patients.
While it’s been around for years, TAVR was initially used as a last-chance option for people with highly severe aortic disease who wouldn’t be healthy enough to endure the intensity of a traditional surgery
